Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Zanella, E. Fermo, P. Bianchi, G. Valentini (2005)
Red cell pyruvate kinase deficiency: molecular and clinical aspectsBritish Journal of Haematology, 130
A. Grimes (1985)
Red Cell Metabolism. A Manual of Biochemical Methods. 3rd EditionBiochemical Society Transactions, 13
A. Zanella, P. Bianchi (2000)
Red cell pyruvate kinase deficiency: from genetics to clinical manifestations.Bailliere's best practice & research. Clinical haematology, 13 1
Ernest Beutler, L. Forman, Ernesto Rios-Larrain (1987)
Elevated pyruvate kinase activity in patients with hemolytic anemia due to red cell pyruvate kinase "deficiency".The American journal of medicine, 83 5
G. Jansen, L. Koenderman, G. Rijksen, B. Cats, G. Staal (1985)
Characteristics of hexokinase, pyruvate kinase, and glucose‐6‐phosphate dehydrogenase during adult and neonatal reticulocyte maturationAmerican Journal of Hematology, 20
F. Oski, B. Marshall, P. Cohen, H. Sugerman, L. Miller (1971)
The role of the left-shifted or right-shifted oxygen-hemoglobin equilibrium curve.Annals of internal medicine, 74 1
A. Kay, W. Kuhl, J. Prchal, E. Beutler (1992)
The origin of glucose-6-phosphate-dehydrogenase (G6PD) polymorphisms in African-Americans.American journal of human genetics, 50 2
R. Hennekam, F. Beemer, B. Cats, G. Jansen, G. Staal (1990)
Hydrops fetalis associated with red cell pyruvate kinase deficiency.Genetic counseling, 1 1
L. Baronciani, Ernest Beutler (1993)
Analysis of pyruvate kinase-deficiency mutations that produce nonspherocytic hemolytic anemia.Proceedings of the National Academy of Sciences of the United States of America, 90
C. Neunert, Geeta Paranjape, S. Cameron, Z. Rogers (2008)
Intravascular hemolysis following low dose daily rifampinPediatric Blood & Cancer, 51
(1989)
Disorders of erythrocyte metabolism
E. Beutler, T. Gelbart (2000)
Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population.Blood, 95 11
Evaluation of two patients with transfusion dependent anemia revealed RBC pyruvate kinase to be 33% and 41% of the mean normal value, with normal or high values of other RBC enzymes. Parental PK activities were just below normal in three of four of the parents. Subsequent DNA analysis revealed both patients to be compound heterozygotes for PKLR gene mutations, two of which are previously undescribed. Borderline low pyruvate kinase activities with increased in other RBC enzyme activities should prompt consideration of measurement of parental enzyme activities, and confirmation by DNA analysis if available. Pediatr Blood Cancer 2008;51:819–821. © 2008 Wiley‐Liss, Inc.
Pediatric Blood & Cancer – Wiley
Published: Dec 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.